Could this Healthcare Stock really climb 1,922.47% in 2023?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Banking Regulators Warns Americans to Pay Attention to Friday]( [Get the Full Story Here]( --------------------------------------------------------------- March 16, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Copper More Critical than Lithium?]( may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found. [See How You Can Benefit From New Copper Discoveries.]( --------------------------------------------------------------- [Algonquin Power & Utilities]( Symbol: [AQN]( Recent Price: $7.64 Average Analyst Price Target: $8.00 (4.71%) Market Cap: $5.27B Last Year's EPS: $0.15 Consensus EPS Forecast: $0.2 Expected Earnings Date: Mar 17 2023 Recent Analyst Action: Dariusz Lozny, analyst at Bank of America Securities, reiterates coverage on [Algonquin Power & Utilities (AQN)]( in the Utilities sector with a Buy rating and a price target of $9.00 (3 weeks ago). [TipRanks.com]( also reports that [Algonquin Power & Utilities]( currently has 9 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $8.00. The target pricing ranges from a high forecast of $10.50 down to a low forecast of $5.12. [Algonquin Power & Utilities (AQN)](’s last closing price was $7.64 which would put the average price target at 4.71% upside. Here are 3rd party ratings for [AQN](: - TipRanks.com: Hold - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Bottom 41% (147 out of 249) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Dividend Stock to Leave for Your Grandchildren]( you tired of your so-called "safe" income stocks slashing dividends while the share prices fall? There is a better way. I just revealed my safest most reliable and [most consistent dividend stock]( - and it pays a sky high yield with dividends paid EVERY month. This company has also increased its monthly dividend twice a year every year for the past 8 years. [Tap here to reveal the name of this stock for free.]( --------------------------------------------------------------- [Vonovia]( Symbol: [VNNVF]( Recent Price: $21.58 Average Analyst Price Target: $37.73 (74.86%) Market Cap: $17.22B Last Year's EPS: -$1.58 Consensus EPS Forecast: $0.58 Expected Earnings Date: Mar 17 2023 Recent Analyst Action: Julian Livingston-Booth, analyst at RBC Capital, reiterates coverage on [Vonovia (VNNVF)]( in the Financial sector with a Buy rating and a price target of $39.73 (2 days ago). [TipRanks.com]( also reports that [Vonovia]( currently has 8 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $37.73. The target pricing ranges from a high forecast of $48.75 down to a low forecast of $27.92. [Vonovia (VNNVF)](’s last closing price was $21.58 which would put the average price target at 74.86% upside. Here are 3rd party ratings for [VNNVF](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [XPeng, Inc. ADR]( Symbol: [XPEV]( Recent Price: $8.1 Average Analyst Price Target: $10.55 (30.25%) Market Cap: $6.76B Last Year's EPS: $0.18 Consensus EPS Forecast: -$0.31 Expected Earnings Date: Mar 17 2023 Recent Analyst Action: Edison Yu, analyst at Deutsche Bank, reiterates coverage on [XPeng, Inc. ADR (XPEV)]( in the Consumer Goods sector with a Buy rating and a price target of $11.00 (1 day ago). [TipRanks.com]( also reports that [XPeng, Inc. ADR]( currently has 7 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $10.55. The target pricing ranges from a high forecast of $12.40 down to a low forecast of $8.92. [XPeng, Inc. ADR (XPEV)](’s last closing price was $8.1 which would put the average price target at 30.25% upside. Here are 3rd party ratings for [XPEV](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 39% (98 out of 249) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [This Plan Could Devastate Your Retirement Savings]( Wall Street insider goes public with the true story of the most harmful action against the wealth of the American people. [See the proof here.]( --------------------------------------------------------------- [Legend Biotech]( Symbol: [LEGN]( Recent Price: $46.91 Average Analyst Price Target: $73.00 (55.62%) Market Cap: $7.90B Last Year's EPS: -$0.3 Consensus EPS Forecast: -$0.38 Expected Earnings Date: Mar 17 2023 Recent Analyst Action: Kostas Biliouris, analyst at BMO Capital, reiterates coverage on [Legend Biotech (LEGN)]( in the Healthcare sector with a Buy rating and a price target of $79.00 (1 month ago). [TipRanks.com]( also reports that [Legend Biotech]( currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $73.00. The target pricing ranges from a high forecast of $79.00 down to a low forecast of $65.00. [Legend Biotech (LEGN)](’s last closing price was $46.91 which would put the average price target at 55.62% upside. Here are 3rd party ratings for [LEGN](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 40% (100 out of 249) [Click for chart >>]( -------------------------------------------------------------------------- [Applied Therapeutics]( Symbol: [APLT]( Recent Price: $0.89 Average Analyst Price Target: $18.00 (1,922.47%) Market Cap: $42.77M Last Year's EPS: -$1.04 Consensus EPS Forecast: -$0.46 Expected Earnings Date: Mar 17 2023 Recent Analyst Action: Brian Skorney, analyst at Robert W. Baird, reiterates coverage on [Applied Therapeutics (APLT)]( in the Healthcare sector with a Buy rating and a price target of $18.00 (3 weeks ago). [TipRanks.com]( also reports that [Applied Therapeutics]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $18.00. The target pricing ranges from a high forecast of $18.00 down to a low forecast of $18.00. [Applied Therapeutics (APLT)](’s last closing price was $0.89 which would put the average price target at 1922.47% upside. Here are 3rd party ratings for [APLT](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Discover this Recession Survival Loophole]( escaping it, 2022 has been brutal. It's been the worst year for stocks in at least five decades. But what if you could make back every penny you've lost in the market this year? Thanks to a new strategy, [you could reverse the tide]( and turn the final quarter of 2022 into the opportunity of a lifetime. [Click here to learn more.]( --------------------------------------------------------------- [Kirkland's]( Symbol: [KIRK]( Recent Price: $2.79 Average Analyst Price Target: $6.75 (141.94%) Market Cap: $36.09M Last Year's EPS: $0.84 Consensus EPS Forecast: -$0.04 Expected Earnings Date: Mar 16 2023 Recent Analyst Action: John Lawrence, analyst at Benchmark Co., reiterates coverage on [Kirkland's (KIRK)]( in the Consumer Goods sector with a Buy rating and a price target of $10.00 (1 month ago). [TipRanks.com]( also reports that [Kirkland's]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.75. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $3.50. [Kirkland's (KIRK)](’s last closing price was $2.79 which would put the average price target at 141.94% upside. Here are 3rd party ratings for [KIRK](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Lithium Americas]( Symbol: [LAC]( Recent Price: $20.21 Average Analyst Price Target: $34.75 (71.94%) Market Cap: $2.86B Last Year's EPS: -$0.06 Consensus EPS Forecast: -$0.22 Expected Earnings Date: Mar 17 2023 Recent Analyst Action: Justin Stevens, analyst at PI Financial, reiterates coverage on [Lithium Americas (LAC)]( in the Basic Materials sector with a Buy rating and a price target of $29.24 (1 week ago). [TipRanks.com]( also reports that [Lithium Americas]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $34.75. The target pricing ranges from a high forecast of $40.00 down to a low forecast of $29.24. [Lithium Americas (LAC)](’s last closing price was $20.21 which would put the average price target at 71.94% upside. Here are 3rd party ratings for [LAC](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 35% (161 out of 249) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [A $226B Copper Spending Jackpot]( November 15, 2021, President Biden signed the biggest infrastructure spending bill of all time. A staggering $226 BILLION is earmarked for projects requiring huge amounts of copper. Turns out, copper is a desperately needed mineral to power the green revolution of clean, renewable energy. [See Who Can Benefit From this Government-backed Initiative.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software